Esanex, Inc. — Form D/A
Esanex, Inc. of INDIANAPOLIS, IN, a company, filed a Form D amendment with the SEC on 2012-06-13. The offering totals $15.5M, of which $4.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-06-13
- Form: D/A
- Accession: 0001531658-12-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $15.5M
- Amount sold: $4.8M
- Remaining: $10.7M
- Investors: 4
- Date of first sale: 2012-04-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-177306
Issuer
- Name: Esanex, Inc.
- CIK: 0001531658
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 115 W. WASHINGTON ST., INDIANAPOLIS, IN, 46204
- Phone: 317-429-0143
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Steven E Hall | Director | Indianapolis, IN |
| Steven E Hall | Executive Officer | Indianapolis, IN |
| Richard Edward Miller | Director | Upper Saddle River, NJ |
| S Edward Torres | Director | Indianapolis, IN |
| S Edward Torres | Executive Officer | Indianapolis, IN |
| Richard Edward Kent | Director | Durham, NC |
| Paul Edward Howard | Director | Newtown, MA |
Other filings by this issuer (3)
More